Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Use and teaching of pneumatic otoscopy in a family medicine residency program.
2013
The current economic burden of cirrhosis.
2011
Emerging therapies for the treatment of hepatitis C
2013 StandoutNobel
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
2018 StandoutNobel
Quantitative Proteomics Identifies Serum Response Factor Binding Protein 1 as a Host Factor for Hepatitis C Virus Entry
2015 StandoutNobel
An overview of clinical decision support systems: benefits, risks, and strategies for success
2020 Standout
A review of economic impact of targeted oral anticancer medications
2013
The global burden of hepatitis C
2009
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review
2008 Standout
Reversion of disease manifestations after HCV eradication
2016
Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
2012
Evolving epidemiology of hepatitis C virus
2010
The use and effectiveness of electronic clinical decision supporttools in the ambulatory/primary care setting: a systematic reviewof the literature
2008
Hepatocellular carcinoma
2016 Standout
Are results of the SF-36 health survey and the nottingham health profile similar?: A comparison in COPD patients
1997
Hepatitis B‐related hepatocellular carcinoma: epidemiological characteristics and disease burden
2009
ESPEN guideline: Clinical nutrition in surgery
2017 Standout
A comparison of the SF‐36 and Nottingham Health Profile in patients with chronic neuropathic pain
2001
Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures
2010 StandoutNobel
Impact of electronic medical record on physician practice in office settings: a systematic review
2012
The COVID-19 pandemic: Impacts on cities and major lessons for urban planning, design, and management
2020 Standout
Spinal cord stimulation versus conventional medical management for neuropathic pain: A multicentre randomised controlled trial in patients with failed back surgery syndrome
2007 Standout
Late Life Function and Disability Instrument: II. Development and Evaluation of the Function Component
2002 Standout
ESPEN Guidelines on Enteral Nutrition: Surgery including Organ Transplantation
2006 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
Current and Future Burden of Chronic Nonmalignant Liver Disease
2015
Global cancer transitions according to the Human Development Index (2008–2030): a population-based study
2012 Standout
Factors that influence the implementation of e-health: a systematic review of systematic reviews (an update)
2016 Standout
Preoperative Immunonutrition: Cost‐Benefit Analysis
2005
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
Global cancer statistics
2011 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence
2012 Standout
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
American Gastroenterological Association Technical Review on the Management of Hepatitis C
2006
Initial findings of shortwave infrared otoscopy in a pediatric population
2018 StandoutNobel
The Impact of eHealth on the Quality and Safety of Health Care: A Systematic Overview
2011 Standout
A Sustained Virologic Response Is Durable in Patients With Chronic Hepatitis C Treated With Peginterferon Alfa-2a and Ribavirin
2010
Comparison of the Efficacy of Lamivudine Plus Adefovir Versus Entecavir in the Treatment of Lamivudine-Resistant Chronic Hepatitis B: A Systematic Review and Meta-Analysis
2013
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM)
2017
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Global Patterns of Cancer Incidence and Mortality Rates and Trends
2010 Standout
The N-terminal Helical Region of the Hepatitis C Virus p7 Ion Channel Protein Is Critical for Infectious Virus Production
2015 StandoutNobel
Dapagliflozin: A Review of Its Use in Patients with Type 2 Diabetes
2014
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Review article: chronic hepatitis B – anti‐viral or immunomodulatory therapy?
2010
Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA
2015 StandoutNobel
Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens
2015 StandoutNobel
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
2006 Standout
A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling
2006
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
Innate Immune Responses to Hepatitis C Virus
2013 StandoutNobel
Systematic Review: Kidney Transplantation Compared With Dialysis in Clinically Relevant Outcomes
2011 Standout
Treatment of HCV Infection by Targeting MicroRNA
2013 Standout
Valuation of air pollution externalities: comparative assessment of economic damage and emission reduction under COVID-19 lockdown
2020
Cost and economic benefit of clinical decision support systems for cardiovascular disease prevention: a community guide systematic review
2016
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Ultrastructural analysis of hepatitis C virus particles
2013 StandoutNobel
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Efficient Replication of Genotype 3a and 4a Hepatitis C Virus Replicons in Human Hepatoma Cells
2012 StandoutNobel
Breast Cancer Treatment
2019 Standout
The SF36 as an outcome measure of services for end stage renal failure.
1998
Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems
2010
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Clinical Practice Guideline: Tympanostomy Tubes in Children
2013
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Epidemics of HIV and sexually transmitted infections in Central Asia
2006
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
2017 Standout
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells
2013 StandoutNobel
Ultrasound Elastography: Review of Techniques and Clinical Applications
2017 Standout
Different Requirements for Scavenger Receptor Class B Type I in Hepatitis C Virus Cell-Free versus Cell-to-Cell Transmission
2013 StandoutNobel
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Industry sponsorship and research outcome
2017 Standout
Clinical Practice Guideline: Otitis Media with Effusion (Update)
2016 Standout
Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B infection
2010
Works of Max Brosa being referenced
[Evidence-based medicine, health costs and treatment of intra-abdominal infection].
1999
The association between asthma control, health care costs, and quality of life in France and Spain
2013
Iatrogenic Cost Factors Incorporating Mild and Moderate Adverse Events in the Economic Comparison of Aceclofenac and Other NSAIDs
2001
Genomic profile of breast cancer: cost–effectiveness analysis from the Spanish National Healthcare System perspective
2014
The health care burden and societal impact of acute otitis media in seven European countries: Results of an Internet survey
2010
Treatment patterns, use of resources, and costs of advanced non-small-cell lung cancer patients in Spain: results from a Delphi panel
2011
Reliability of the Spanish version of the Nottingham health profile in patients with stable end-stage renal disease
1994
Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis C
2005
Modeling the cost-effectiveness of different oral antiviral therapies in patients with chronic hepatitis B
2009
Estimating the future health burden of chronic hepatitis B and the impact of therapy in Spain
2008
Cost-Effectiveness Analysis of Dapaglifozin Versus Other T2DM Treatments in the Spanish Context
2013
558 COST-EFFECTIVENESS SIMULATION ANALYSIS OF TENOFOVIR DISOPROXIL FUMARATE (TENOFOVIR), LAMIVUDINE, ADEFOVIR DIPIVOXIL (ADEFOVIR) AND ENTECAVIR OF HBEAG NEGATIVE (-) PATIENTS WITH CHRONIC HEPATITIS-B (CHB) IN SPAIN
2008
Impact of a Clinical Decision Support System on the Management of Patients with Hypercholesterolemia in the Primary Healthcare Setting
2005